Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amelie Plymoth

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Opinion in Oncology|December 7, 2011
Cancer as a metabolic diseasePierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 23, 2016
More chinks in the armor of cancer: potential for new therapiesPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 15, 2012
Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapyPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 15, 2013
The genetic-metabolic duality of cancerPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|February 16, 2011
Biomarkers in cancer research and treatment: promises and challengesPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 26, 2010
Proteomics beyond proteomics: toward clinical applicationsAmelie Plymoth, Pierre Hainaut
Clinical Epidemiology|August 20, 2016
Letter to the editorAnnika Linde, Amelie Plymoth
Current Opinion in Oncology|November 25, 2015
Editorial: from cancer genotypes to phenotypes: a never-ending complexityPierre Hainaut, Amelie Plymoth
Cancer Letters|October 20, 2009
Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer preventionAmelie Plymoth, Simonetta Viviani, Pierre Hainaut
Cancer Letters|April 10, 2009
Editorial foreword special issue "hepatocellular carcinoma--a worldwide translational approach"Amelie Plymoth, Isabelle Chemin, Paolo Boffetta, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Opinion in Oncology|December 7, 2011
Cancer as a metabolic diseasePierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 23, 2016
More chinks in the armor of cancer: potential for new therapiesPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 15, 2012
Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapyPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 15, 2013
The genetic-metabolic duality of cancerPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|February 16, 2011
Biomarkers in cancer research and treatment: promises and challengesPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 26, 2010
Proteomics beyond proteomics: toward clinical applicationsAmelie Plymoth, Pierre Hainaut
Clinical Epidemiology|August 20, 2016
Letter to the editorAnnika Linde, Amelie Plymoth
Current Opinion in Oncology|November 25, 2015
Editorial: from cancer genotypes to phenotypes: a never-ending complexityPierre Hainaut, Amelie Plymoth
Cancer Letters|October 20, 2009
Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer preventionAmelie Plymoth, Simonetta Viviani, Pierre Hainaut
Cancer Letters|April 10, 2009
Editorial foreword special issue "hepatocellular carcinoma--a worldwide translational approach"Amelie Plymoth, Isabelle Chemin, Paolo Boffetta, et al.
Pageof 5